Table 4 Management of women with Amniotic Fluid Embolism, Australia and New Zealand 2010-2011
From: Amniotic fluid embolism: an Australian-New Zealand population-based study
Number of women (%) | |||
|---|---|---|---|
Median (IQR) | |||
Transfer to other hospital site | 7 (21 %) | ||
Hysterectomy | 6 (18 %) | ||
Plasmaphoresis | 2 (6 %) | ||
Recombinant Factor VIIa | 8 (24 %) | ||
Intubation/Ventilation | 14 (42 %) | ||
ECMO | 0 (0 %) | ||
CPR | 14 (42 %) | ||
Blood and blood products | Yes | 28 (85 %) | |
Red Cells | 28 (85 %) | 9.5 (5.3–13.8) | |
Fresh Frozen Plasma | 24 (73 %) | 6.0 (4–8.75) | |
Cyroprecipitate | 24 (73 %) | 9.0 (4.3–20) | |
Platelets | 19 (58 %) | 3.0 (2.0–4.0) | |
Blood Results (Worst recorded) | Haemoglobin <7 g/dl | 17 (52 %) | |
Fibrinogen <2 g/dl | 21 (64 %) | ||
Platelets <100 109/L | 20 (61 %) | ||
INR >1.5 | 16 (48 %) | ||
Level of care required | Required admission to ICU | 20 (61 %) | |
Required admission to HDU only | 8 (24 %) | ||
Died prior to accessing ICU/HDU | 3 (9 %) | ||
Did not require ICU or HDU care | 1 (3 %) | ||